Page last updated: 2024-09-02
alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol and Brain Ischemia
alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol has been researched along with Brain Ischemia in 2 studies
Research
Studies (2)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Canney, M; Earley, B; Junien, JL; Leonard, BE; O'Neill, M | 1 |
Contreras, PC; Gray, NM; Lanthorn, TH; Ragan, DM | 1 |
Other Studies
2 other study(ies) available for alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol and Brain Ischemia
Article | Year |
---|---|
The novel sigma ligand JO 1994 protects against ischaemia-induced behavioural changes, cell death and receptor dysfunction in the gerbil.
Topics: Animals; Anti-Anxiety Agents; Autoradiography; Behavior, Animal; Brain; Brain Chemistry; Brain Ischemia; Cell Death; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Gerbillinae; Male; Motor Activity; Muscarinic Antagonists; Neuroprotective Agents; Organic Chemicals; Pyrimidines; Quinuclidinyl Benzilate; Receptors, sigma | 1996 |
BMY-14802 protects against ischemia-induced neuronal damage in the gerbil.
Topics: Animals; Behavior, Animal; Brain Ischemia; Carotid Arteries; Gerbillinae; Hippocampus; Neurons; Psychotropic Drugs; Pyrimidines | 1992 |